Advertisement

Transcatheter Therapy for Aortic Stenosis: A Review of the Literature

  • Davide Capodanno
  • Simona Gulino
Chapter

Abstract

“Even if the development of transcatheter aortic valve implantation (TAVI) can be considered a success story today, it is nothing short of a miracle, as the project appeared particularly challenging - not to say totally unrealistic - at its origin in the early 1990s.” These are the words that Cribier used to define the history of TAVI as a genuine odyssey, which, however, over the years has been increasingly recognized as a revolutionary technique in aortic valve stenosis (AS).

References

  1. 1.
    Letac B, Cribier A, Koning R, Bellefleur JP. Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis. Am J Cardiol. 1988;62(9):598–605.CrossRefPubMedGoogle Scholar
  2. 2.
    Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84(6):2383–97.Google Scholar
  3. 3.
    Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–70.CrossRefPubMedGoogle Scholar
  7. 7.
    Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–50.CrossRefPubMedGoogle Scholar
  9. 9.
    Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.CrossRefPubMedGoogle Scholar
  10. 10.
    Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29(11):1463–70.CrossRefPubMedGoogle Scholar
  11. 11.
    Eltchaninoff H, Prat A, Gilard M, et al. On behalf of the FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705–15.CrossRefPubMedGoogle Scholar
  13. 13.
    Zahn R, Gerckens U, Grube E, et al. On behalf of the German Transcatheter Aortic Valve Interventions—Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2001;32:198–204.CrossRefGoogle Scholar
  14. 14.
    Walther T, Hamm CW, Schuler G, et al., on behalf of the GARY Executive Board. Perioperative results and complications in 15,964 transcatheter aortic valve replacements. Prospective data from the GARY Registry. J Am Coll Cardiol. 2015;65(20):2173–80.Google Scholar
  15. 15.
    Tamburino C, Capodanno D, Mulè M, et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prothesis. J Invasive Cardiol. 2009;21:93–8.PubMedGoogle Scholar
  16. 16.
    Ussia GP, Barbanti M, Petronio AS, et al., on behalf of the CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J. 2012;33(8):969–76.Google Scholar
  17. 17.
    Barbanti M, Petronio AS, Ettori F, et al. 5-Year outcomes after transcatheter aortic valve implantation with CoreValve prosthesis. JACC Cardiovasc Interv. 2015;8(8):1084–91.CrossRefPubMedGoogle Scholar
  18. 18.
    Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Duncan A, Ludman P, Banya W, et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis. The U.K. Transcatheter Aortic Valve Implantation Registry. JACC Cardiovasc Interv. 2015:645–53.Google Scholar
  20. 20.
    Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation. 2015;131(13):1181–90.CrossRefPubMedGoogle Scholar
  21. 21.
    Mack MJ, Brennan JM, Brindis R, et al., STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069–77.Google Scholar
  22. 22.
    Holmes DR Jr, Brennan JM, Rumsfeld JS, et al. STS/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313(10):1019–28.Google Scholar
  23. 23.
    Holmes DR Jr, Nishimura RA, Grover FL, et al. STS/ACC TVT Registry. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. J Am Coll Cardiol. 2015 Dec 29;66(25):2813–23. .Google Scholar
  24. 24.
    Rode’s-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080–90.CrossRefGoogle Scholar
  25. 25.
    Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation; insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–75.CrossRefPubMedGoogle Scholar
  26. 26.
    Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–33.CrossRefPubMedGoogle Scholar
  28. 28.
    Schymik G, Lefèvre T, Bartorelli AL, et al. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv. 2015;8(5):657–69.CrossRefPubMedGoogle Scholar
  29. 29.
    SOURCE 3 post-approval registry - early outcomes in 1,946 TAVI patients with a third-generation balloon expandable transcatheter heart valve. Presented by O Wendler at EuroPCR 2016.Google Scholar
  30. 30.
    Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J. 2014;35:2672–84.CrossRefPubMedGoogle Scholar
  31. 31.
    Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients with Severe Aortic Stenosis at Extreme Risk for Surgery. J Am Coll Cardiol. 2014, 1972;63(19):–81.Google Scholar
  32. 32.
    Piazza N, van Gameren M, Jüni P, et al. A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study. EuroIntervention. 2009;5:580–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Tamburino C, Barbanti M, Capodanno D, et al. Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis. Am J Cardiol. 2012;109(10):1487–93.CrossRefPubMedGoogle Scholar
  34. 34.
    Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv. 6(5, 2013):443–51.Google Scholar
  35. 35.
    Wenaweser P, Stortecky S, Schwander S, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J. 2013;34:1894–905.CrossRefPubMedGoogle Scholar
  36. 36.
    Tamburino C, Barbanti M, D’Errigo P, et al. 1-Year outcomes after transfemoral transcatheter or surgical aortic valve replacement. Results from the Italian OBSERVANT Study. J Am Coll Cardiol. 2015;66(7):804–12.CrossRefPubMedGoogle Scholar
  37. 37.
    Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–25.CrossRefPubMedGoogle Scholar
  38. 38.
    Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMedGoogle Scholar
  39. 39.
    Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.CrossRefPubMedGoogle Scholar
  40. 40.
    Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18):1696–704.CrossRefPubMedGoogle Scholar
  41. 41.
    Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–91.CrossRefPubMedGoogle Scholar
  42. 42.
    Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic valve replacement. N Engl J Med. 2012;366:1686–95.CrossRefPubMedGoogle Scholar
  43. 43.
    Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84.CrossRefPubMedGoogle Scholar
  44. 44.
    Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefPubMedGoogle Scholar
  45. 45.
    Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94.CrossRefPubMedGoogle Scholar
  47. 47.
    Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement. The CHOICE Randomized Clinical Trial. JAMA. 2014;311(15):1503–14.CrossRefPubMedGoogle Scholar
  49. 49.
    Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.CrossRefPubMedGoogle Scholar
  50. 50.
    Gargiulo G, Sannino A, Capodanno D, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a systematic review and meta-analysis. Ann Intern Med. 2016;165(5):334–44.CrossRefPubMedGoogle Scholar
  51. 51.
    Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8(10):1359–67.CrossRefPubMedGoogle Scholar
  52. 52.
    Kempfert J, Holzhey D, Hofmann S, et al. First registry results from the newly approved ACURATE TA™ TAVI system. Eur J Cardiothorac Surg. 2015;48(1):137–41.CrossRefPubMedGoogle Scholar
  53. 53.
    Meredith IT, Worthley SG, Whitbourn RJ, et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention. 2014;9(11):1264–70.CrossRefPubMedGoogle Scholar
  54. 54.
    Meredith IT, Walters DL, Dumonteil N, et al. 1-year outcomes with the fully repositionable and retrievable lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II Study. JACC Cardiovasc Interv. 2016;9(4):376–84.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Ferrarotto HospitalUniversity of CataniaCataniaItaly
  2. 2.Division of Cardiology – Ferrarotto HospitalUniversity of CataniaCataniaItaly

Personalised recommendations